The MSCI World ETF Faces a Squeeze: Tech Earnings, Index Overhaul, and a Fee War Collide

iShares MSCI World ETF navigates tech earnings from Alphabet, Microsoft, Apple, and a looming MSCI methodology change that could reshape portfolio weights.

The iShares MSCI World ETF (URTH) is navigating one of its most complex periods in recent memory, with a convergence of corporate earnings, structural index changes, and competitive pressures that could reshape its trajectory. The fund, which tracks developed-market equities across 23 countries, enters the final week of April with its heaviest hitters set to report—while a looming methodology shift from MSCI threatens to upend portfolio weights as early as next year.

Tech Giants Take Center Stage

Alphabet, Microsoft, and Apple are all due to deliver quarterly results within a 48-hour window starting April 29. Together, these three stocks account for more than 13% of URTH’s roughly $103 billion in assets under management. Nvidia, the fund’s largest single holding at 5.29%, adds another layer of concentration risk in a technology sector that makes up nearly 27% of the portfolio.

Alphabet reports first, with investors zeroing in on whether the company’s massive capital expenditure plans—projected at $175 billion to $185 billion for 2026, nearly double last year’s $91.4 billion—are translating into tangible growth from Google Cloud. The stock has already rallied 18% in the past 30 days, leaving it priced for perfection. Morningstar assigns Alphabet a fair value estimate of $340 per share, suggesting the current price leaves little room for disappointment.

Microsoft follows on April 29 after the US market close, carrying a 3.17% weight in URTH. The company posted 17% revenue growth last quarter, with Azure surging 39%. But TD Cowen recently trimmed its price target to $540, citing GPU infrastructure bottlenecks that could temper near-term momentum. Apple closes the trilogy on April 30, with analysts forecasting second-quarter revenue growth between 13% and 16%. The iPhone maker commands a 4.55% slice of the fund.

Banks Set a High Bar

The financial sector has already delivered a strong earnings season, providing a stabilizing counterweight to the tech-heavy portfolio. Morgan Stanley posted a 29% jump in net income to $5.57 billion, marking its first-ever quarter with revenue exceeding $20 billion. JPMorgan Chase notched a record trading revenue of $11.6 billion, roughly 9% above analyst estimates. With financials representing about 16% of URTH’s holdings—the second-largest sector allocation—these results have helped cushion the fund ahead of tech’s turn in the spotlight.

FactSet data shows the S&P 500 is on track for its sixth consecutive quarter of double-digit earnings growth, the longest such streak in over a decade. But the bar is now high for technology names to sustain that momentum.

MSCI’s Methodological Shift Looms

Beyond the earnings calendar, a structural change is brewing. MSCI plans to implement a revised free-float calculation methodology during its May 2026 index review. The reform introduces a three-tier classification system under which equity total-return swaps between non-free-float and free-float shareholders will be reclassified as non-free-float. The update also adjusts threshold calculations for insurance companies in select European markets and for sovereign wealth funds operating outside their home countries.

The practical effect for URTH: elevated portfolio turnover, well beyond the level of routine quarterly rebalancing. Mega-cap weights—particularly Nvidia’s—could shift materially, forcing fund managers to adjust positions in a compressed timeframe.

Fee Pressure Intensifies

URTH’s expense ratio of 0.24% is coming under increasing scrutiny. Invesco slashed the fee on its competing MSCI World ETF to 0.05% on April 1, widening the cost gap to 19 basis points. BlackRock, which manages URTH, points to the fund’s tracking difference of just 0.02% as a quality differentiator. So far, institutional loyalty appears intact: the Royal Bank of Canada increased its stake by 17.5% in the fourth quarter of 2025, bringing its holdings to roughly two million shares.

Morningstar awards URTH a Bronze rating, but flags the fee as a concern relative to peers. Among 298 funds in the Global Large-Stock Blend category, the ETF remains a benchmark choice—but the pricing pressure is unlikely to let up.

Pharma Tariffs Add Sector Risk

A separate headwind comes from Washington. The US administration announced in early April that it would impose tariffs on imported pharmaceutical products, with rates reaching as high as 100% for manufacturers without US pricing agreements. EU and Asian producers face a 15% levy, set to take effect at the end of July. The healthcare sector accounts for roughly 9.5% of URTH’s portfolio, enough to create a noticeable drag if trade tensions escalate.

FactSet has already trimmed its S&P 500 earnings growth forecast for the current period from 13.4% to 12.5%, partly reflecting the tariff uncertainty.

Technical Signals Flash Caution

URTH closed recently at $195.27, within striking distance of its 52-week high of $195.79. But the relative strength index stands at 94.6—deep into overbought territory. A golden cross formed in mid-April, with the 10-day moving average crossing above the 50-day average, a pattern that often signals further upside but can also precede a pullback.

The next 48 hours will test whether the fund’s tech-heavy composition can justify its elevated valuation—or whether the concentration in a handful of mega-caps leaves it exposed to a sharp correction. With an index overhaul, a fee war, and sector-specific tariffs all in play, the MSCI World ETF is facing pressure from more angles than a single earnings season can easily resolve.